Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | RBL1 | Human | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of RBL1 mRNA | CTD | PMID:23649840 | RBL1 | Human | (S)-nicotine | multiple interactions | EXP | | 6480464 | Nicotine inhibits the reaction [RBL1 protein binds to CDC25A promoter] and Nicotine inhibits the reaction [RBL1 protein binds to CDC6 promoter] | CTD | PMID:16862215 | RBL1 | Human | 1,1-dichloroethene | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of RBL1 mRNA | CTD | PMID:26682919 | RBL1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RBL1 mRNA | CTD | PMID:22206623 | RBL1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of RBL1 mRNA | CTD | PMID:22206623 | RBL1 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | EGF protein inhibits the reaction [Estradiol results in increased expression of RBL1 mRNA] | CTD | PMID:24758408 | RBL1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of RBL1 mRNA | CTD | PMID:24758408 | RBL1 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | RBL1 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | RBL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA] | CTD | PMID:11007951 | RBL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RBL1 mRNA | CTD | PMID:32109520 and PMID:33387578 | RBL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RBL1 mRNA | CTD | PMID:23152189 | RBL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rbl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RBL1 mRNA | CTD | PMID:21570461 | RBL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA | CTD | PMID:15667827 | RBL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA | CTD | PMID:11007951 | RBL1 | Human | 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Oxazolone results in increased expression of RBL1 mRNA | CTD | PMID:11379042 | RBL1 | Human | 4-hydroxynon-2-enal | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of RBL1 mRNA | CTD | PMID:19191707 | RBL1 | Human | 4-nitrophenol | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | 4-nitrophenol results in decreased expression of RBL1 mRNA | CTD | PMID:34673133 | RBL1 | Human | 5-aza-2'-deoxycytidine | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Decitabine results in decreased expression of RBL1 mRNA | CTD | PMID:27915011 | RBL1 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of RBL1 mRNA | CTD | PMID:24780913 | RBL1 | Human | acetamide | increases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of RBL1 mRNA | CTD | PMID:31881176 | RBL1 | Human | aflatoxin B1 | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of RBL1 mRNA | CTD | PMID:19770486 | RBL1 | Human | all-trans-retinoic acid | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Tretinoin results in increased expression of RBL1 protein | CTD | PMID:15231690 | RBL1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RBL1 mRNA | CTD | PMID:33167477 | RBL1 | Human | alvocidib | decreases expression | EXP | | 6480464 | alvocidib results in decreased expression of RBL1 protein | CTD | PMID:9829756 | RBL1 | Human | amphetamine | decreases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of RBL1 mRNA | CTD | PMID:30779732 | RBL1 | Human | antimycin A | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Antimycin A results in decreased expression of RBL1 mRNA | CTD | PMID:19304788 | RBL1 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of RBL1 mRNA | CTD | PMID:24449571 | RBL1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of RBL1 mRNA | CTD | PMID:33212167 | RBL1 | Human | arsenous acid | decreases methylation | EXP | | 6480464 | Arsenic Trioxide results in decreased methylation of RBL1 promoter | CTD | PMID:29159499 | RBL1 | Human | atrazine | multiple interactions | EXP | | 6480464 | [Atrazine co-treated with Arsenates] results in increased expression of RBL1 mRNA | CTD | PMID:18585445 | RBL1 | Human | benzo[a]pyrene | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of RBL1 mRNA | CTD | PMID:19770486 | RBL1 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of RBL1 mRNA | CTD | PMID:32234424 and PMID:33411230 | RBL1 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of RBL1 promoter | CTD | PMID:27901495 | RBL1 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20382639 | RBL1 | Human | bis(2-chloroethyl) sulfide | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of RBL1 mRNA | CTD | PMID:15674843 | RBL1 | Human | bis(2-chloroethyl) sulfide | decreases expression | EXP | | 6480464 | Mustard Gas results in decreased expression of RBL1 mRNA | CTD | PMID:33491125 | RBL1 | Human | bisphenol A | decreases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of RBL1 mRNA | CTD | PMID:25181051 | RBL1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RBL1 protein | CTD | PMID:32981897 | RBL1 | Human | bisphenol A | increases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of RBL1 mRNA | CTD | PMID:32145629 | RBL1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RBL1 mRNA | CTD | PMID:29275510 | RBL1 | Human | bisphenol A | multiple interactions | ISO | Rbl1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Genistein] results in increased methylation of RBL1 gene | CTD | PMID:28505145 | RBL1 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of RBL1 mRNA | CTD | PMID:26079696 | RBL1 | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of RBL1 protein | CTD | PMID:35688186 | RBL1 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of RBL1 mRNA | CTD | PMID:21592394 | RBL1 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA | CTD | PMID:21592394 | RBL1 | Human | calyculin a | multiple interactions | EXP | | 6480464 | calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein] | CTD | PMID:12621062 | RBL1 | Human | camptothecin | decreases expression | EXP | | 6480464 | Camptothecin results in decreased expression of RBL1 protein | CTD | PMID:15585644 | RBL1 | Human | cannabidiol | decreases expression | EXP | | 6480464 | Cannabidiol results in decreased expression of RBL1 mRNA | CTD | PMID:36519830 | RBL1 | Human | carbon nanotube | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | RBL1 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RBL1 gene] | CTD | PMID:28238834 | RBL1 | Human | chloroprene | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of RBL1 mRNA | CTD | PMID:23125180 | RBL1 | Human | chlorpyrifos | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of RBL1 mRNA | CTD | PMID:20350560 | RBL1 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of RBL1 mRNA | CTD | PMID:19320972 and PMID:19376846 | RBL1 | Human | copper atom | multiple interactions | EXP | | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of RBL1 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of RBL1 mRNA | CTD | PMID:20971185 and PMID:30911355 | RBL1 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of RBL1 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of RBL1 mRNA | CTD | PMID:20971185 and PMID:30911355 | RBL1 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of RBL1 mRNA | CTD | PMID:19549813 | RBL1 | Human | cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA] more ... | CTD | PMID:11007951 and PMID:20100483 | RBL1 | Human | cycloheximide | decreases expression | EXP | | 6480464 | Cycloheximide results in decreased expression of RBL1 protein | CTD | PMID:20100483 | RBL1 | Human | D-mannitol | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Mannitol results in decreased expression of RBL1 mRNA | CTD | PMID:25270620 | RBL1 | Human | diarsenic trioxide | decreases methylation | EXP | | 6480464 | Arsenic Trioxide results in decreased methylation of RBL1 promoter | CTD | PMID:29159499 | RBL1 | Human | dibutyl phthalate | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of RBL1 mRNA | CTD | PMID:17361019 and PMID:21266533 | RBL1 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of RBL1 protein | CTD | PMID:16537896 | RBL1 | Human | folic acid | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RBL1 mRNA | CTD | PMID:22206623 | RBL1 | Human | folic acid | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of RBL1 mRNA | CTD | PMID:25629700 | RBL1 | Human | folic acid | increases expression | EXP | | 6480464 | Folic Acid results in increased expression of RBL1 mRNA | CTD | PMID:21867686 | RBL1 | Human | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of RBL1 protein | CTD | PMID:37730182 | RBL1 | Human | furan | increases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | furan results in increased expression of RBL1 mRNA | CTD | PMID:22079235 | RBL1 | Human | genistein | multiple interactions | ISO | Rbl1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Genistein] results in increased methylation of RBL1 gene | CTD | PMID:28505145 | RBL1 | Human | gentamycin | decreases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of RBL1 mRNA | CTD | PMID:33387578 | RBL1 | Human | glyphosate | decreases expression | EXP | | 6480464 | Glyphosate results in decreased expression of RBL1 mRNA | CTD | PMID:31295307 | RBL1 | Human | GW 3965 | decreases expression | EXP | | 6480464 | GW 3965 results in decreased expression of RBL1 mRNA | CTD | PMID:31437187 | RBL1 | Human | hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA | CTD | PMID:17183730 | RBL1 | Human | hydrogen peroxide | multiple interactions | EXP | | 6480464 | calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein] and Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein] | CTD | PMID:12621062 | RBL1 | Human | hydrogen peroxide | decreases phosphorylation | EXP | | 6480464 | Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein | CTD | PMID:12621062 | RBL1 | Human | irinotecan | decreases expression | EXP | | 6480464 | Irinotecan metabolite results in decreased expression of RBL1 mRNA and Irinotecan results in decreased expression of RBL1 mRNA | CTD | PMID:15956246 | RBL1 | Human | lamivudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA | CTD | PMID:15784690 | RBL1 | Human | Lasiocarpine | multiple interactions | EXP | | 6480464 | [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBL1 mRNA | CTD | PMID:33884520 | RBL1 | Human | lidocaine | affects expression | ISO | Rbl1 (Mus musculus) | 6480464 | Lidocaine affects the expression of RBL1 mRNA | CTD | PMID:18931217 | RBL1 | Human | lidocaine | increases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of RBL1 mRNA | CTD | PMID:35283115 | RBL1 | Human | lipopolysaccharide | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of RBL1 mRNA | CTD | PMID:10975854 | RBL1 | Human | LY294002 | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of RBL1 protein | CTD | PMID:15601625 | RBL1 | Human | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of RBL1 mRNA | CTD | PMID:24449571 | RBL1 | Human | methoxyacetic acid | multiple interactions | ISO | Rbl1 (Rattus norvegicus) | 6480464 | methoxyacetic acid results in decreased phosphorylation of and results in decreased expression of RBL1 protein | CTD | PMID:11313878 | RBL1 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of RBL1 mRNA | CTD | PMID:28001369 | RBL1 | Human | monocrotaline | multiple interactions | EXP | | 6480464 | [CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of RBL1 mRNA | CTD | PMID:33884520 | RBL1 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of RBL1 protein | CTD | PMID:20100483 | RBL1 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases ubiquitination | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of RBL1 protein | CTD | PMID:20100483 | RBL1 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [palbociclib results in decreased expression of RBL1 protein] and palbociclib promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of RBL1 protein] | CTD | PMID:20100483 | RBL1 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RBL1 mRNA more ... | CTD | PMID:17854601 more ... | RBL1 | Human | N-nitrosodiethylamine | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of RBL1 mRNA and Diethylnitrosamine results in increased expression of RBL1 protein | CTD | PMID:17854601 and PMID:19887370 | RBL1 | Human | nicotine | multiple interactions | EXP | | 6480464 | Nicotine inhibits the reaction [RBL1 protein binds to CDC25A promoter] and Nicotine inhibits the reaction [RBL1 protein binds to CDC6 promoter] | CTD | PMID:16862215 | RBL1 | Human | okadaic acid | multiple interactions | EXP | | 6480464 | Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein] | CTD | PMID:12621062 | RBL1 | Human | oxaliplatin | multiple interactions | ISO | Rbl1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RBL1 mRNA | CTD | PMID:25729387 | RBL1 | Human | oxaliplatin | decreases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | oxaliplatin results in decreased expression of RBL1 mRNA | CTD | PMID:25729387 | RBL1 | Human | oxybenzone | increases expression | EXP | | 6480464 | oxybenzone results in increased expression of RBL1 mRNA | CTD | PMID:36581016 | RBL1 | Human | ozone | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RBL1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RBL1 mRNA | CTD | PMID:34911549 | RBL1 | Human | palbociclib | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [palbociclib results in decreased expression of RBL1 protein] more ... | CTD | PMID:20100483 | RBL1 | Human | palbociclib | decreases expression | EXP | | 6480464 | palbociclib results in decreased expression of RBL1 mRNA and palbociclib results in decreased expression of RBL1 protein | CTD | PMID:20100483 and PMID:20473330 | RBL1 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RBL1 mRNA | CTD | PMID:22230336 | RBL1 | Human | paracetamol | increases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of RBL1 mRNA | CTD | PMID:33387578 | RBL1 | Human | PCB138 | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | RBL1 | Human | phenobarbital | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of RBL1 mRNA | CTD | PMID:19482888 | RBL1 | Human | phenobarbital | affects expression | ISO | Rbl1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of RBL1 mRNA | CTD | PMID:23091169 | RBL1 | Human | phenobarbital | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RBL1 mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RBL1 mRNA] | CTD | PMID:19482888 and PMID:24535843 | RBL1 | Human | pirinixic acid | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of RBL1 mRNA and PPARA protein promotes the reaction [pirinixic acid results in increased expression of RBL1 mRNA] | CTD | PMID:17950772 and PMID:20813756 | RBL1 | Human | pirinixic acid | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of RBL1 mRNA | CTD | PMID:17950772 and PMID:20813756 | RBL1 | Human | pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:23626729 | RBL1 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of RBL1 mRNA | CTD | PMID:23727915 | RBL1 | Human | quercetin | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Quercetin results in increased expression of RBL1 mRNA | CTD | PMID:25862958 | RBL1 | Human | raloxifene | decreases phosphorylation | EXP | | 6480464 | Raloxifene Hydrochloride results in decreased phosphorylation of RBL1 protein | CTD | PMID:26660119 | RBL1 | Human | riddelliine | multiple interactions | EXP | | 6480464 | [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBL1 mRNA | CTD | PMID:33884520 | RBL1 | Human | ritonavir | increases expression | EXP | | 6480464 | Ritonavir results in increased expression of RBL1 mRNA | CTD | PMID:19386116 | RBL1 | Human | rotenone | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Rotenone results in decreased expression of RBL1 mRNA | CTD | PMID:19304788 | RBL1 | Human | rotenone | decreases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of RBL1 mRNA | CTD | PMID:28374803 | RBL1 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of RBL1 mRNA | CTD | PMID:25895662 | RBL1 | Human | silver(1+) nitrate | increases expression | EXP | | 6480464 | Silver Nitrate analog results in increased expression of RBL1 mRNA and Silver Nitrate results in increased expression of RBL1 mRNA | CTD | PMID:22831968 | RBL1 | Human | sirolimus | multiple interactions | EXP | | 6480464 | [TGFB1 protein co-treated with Sirolimus] inhibits the reaction [[E2F4 protein binds to RBL1 protein] which binds to CDK2 protein] | CTD | PMID:12417722 | RBL1 | Human | sodium arsenite | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of RBL1 mRNA | CTD | PMID:16014739 | RBL1 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of RBL1 mRNA | CTD | PMID:38568856 | RBL1 | Human | succimer | multiple interactions | ISO | Rbl1 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBL1 mRNA | CTD | PMID:21641980 | RBL1 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of RBL1 mRNA | CTD | PMID:31533062 | RBL1 | Human | tamoxifen | increases phosphorylation | ISO | Rbl1 (Mus musculus) | 6480464 | Tamoxifen results in increased phosphorylation of RBL1 protein | CTD | PMID:15642790 | RBL1 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of RBL1 mRNA | CTD | PMID:21592394 | RBL1 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA | CTD | PMID:21592394 | RBL1 | Human | tetrachloromethane | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of RBL1 mRNA and Carbon Tetrachloride results in increased expression of RBL1 protein | CTD | PMID:19887370 and PMID:31919559 | RBL1 | Human | thioacetamide | increases expression | ISO | Rbl1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of RBL1 mRNA | CTD | PMID:23411599 and PMID:34492290 | RBL1 | Human | titanium dioxide | decreases methylation | ISO | Rbl1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of RBL1 promoter | CTD | PMID:35295148 | RBL1 | Human | toluene 2,4-diisocyanate | increases expression | ISO | Rbl1 (Mus musculus) | 6480464 | Toluene 2 and 4-Diisocyanate results in increased expression of RBL1 mRNA | CTD | PMID:11379042 | RBL1 | Human | topotecan | multiple interactions | ISO | Rbl1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RBL1 mRNA | CTD | PMID:25729387 | RBL1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of RBL1 mRNA | CTD | PMID:37042841 | RBL1 | Human | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of RBL1 mRNA | CTD | PMID:19140230 | RBL1 | Human | trovafloxacin | decreases expression | ISO | Rbl1 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of RBL1 mRNA | CTD | PMID:35537566 | RBL1 | Human | valproic acid | affects expression | ISO | Rbl1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of RBL1 mRNA | CTD | PMID:17963808 | RBL1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of RBL1 mRNA | CTD | PMID:28001369 | RBL1 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA | CTD | PMID:17183730 | RBL1 | Human | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of RBL1 mRNA | CTD | PMID:23649840 | RBL1 | Human | zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA | CTD | PMID:15784690 | |